.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Army
Covington
Daiichi Sankyo
Argus Health
Johnson and Johnson
Express Scripts
Accenture
Colorcon
McKesson

Generated: November 24, 2017

DrugPatentWatch Database Preview

Diltiazem malate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diltiazem malate and what is the scope of diltiazem malate patent protection?

Diltiazem malate
is the generic ingredient in two branded drugs marketed by Merck and Biovail, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for diltiazem malate.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-003Oct 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-002Oct 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-001Oct 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: diltiazem malate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-001Oct 4, 1996► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-002Oct 4, 1996► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-003Oct 4, 1996► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-003Oct 4, 1996► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-002Oct 4, 1996► Subscribe► Subscribe
Merck
TIAMATE
diltiazem malate
TABLET, EXTENDED RELEASE;ORAL020506-001Oct 4, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Fish and Richardson
Teva
Cantor Fitzgerald
Cerilliant
Healthtrust
Chinese Patent Office
Chubb
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot